Giving contamination time to build up can cause headaches for more than just your company.
This article was also published in our US sister publication Pharmaceutical Technology and can be read here.
|Outsourcing OutlookJim MillerBio/Pharma Funding Challenges Could Hurt CDMOs in 2017|
|Regulatory Watch Jill Wechsler FDA and Manufacturers Intensify Concerns about Data Integrity|
|EU Regulatory Watch Sean Milmo Pharmaceuticals in the Environment Spark Controversy|
EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.
Patheon launches initial public offering to repay outstanding notes and expenses.